![](/img/cover-not-exists.png)
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
AlHilli, Mariam M., Becker, Marc A., Weroha, S. John, Flatten, Karen S., Hurley, Rachel M., Harrell, Maria I., Oberg, Ann L., Maurer, Matt J., Hawthorne, Kieran M., Hou, Xiaonan, Harrington, Sean C.,Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.08.328
Date:
September, 2016
File:
PDF, 2.02 MB
english, 2016